Finland· FI-REL-REL402

Diligan

A hydroxyzin, kombinationen product containing nicotinic acid + meclozine dihydrochloride + hydroxyzine hydrochloride, registered in Finland by UCB S.P.A. Division.

ATC N05BB51

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedDiliganATCN05BB51REGISTER NO.FI-REL-REL402PACKS LISTED0CHECKEDSeptember 27, 2026

The record

At a glance

Fimea (Finland)
Active substance
Nicotinic acid + Meclozine dihydrochloride + Hydroxyzine hydrochloride
Manufacturer
UCB S.P.A. Division
Country
Finland (FI)
ATC code
N05BB51
ATC class
Hydroxyzin, Kombinationen
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/881327bf-00e0-4236-a6d4-ccac985cc928
GET /v1/drugs/881327bf-00e0-4236-a6d4-ccac985cc928?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "4",
  "form": "tabletti",
  "route": null,
  "ddd_unit": "ED",
  "strength": null,
  "atc_label": "hydroksitsiini, yhdistelmävalmisteet",
  "ma_number": "3657",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL402",
  "authorised_at": "1966-06-22"
}

See everything about hydroxyzin, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.